Research output per year
Research output per year
Personal profile
Biography
Dr Victor M. Oguoma (BSc, MScPH, MBiostat, PhD) is a Senior Research Fellow/Biostatistician at the Health Research Institute, University of Canberra (HRI-UC). He has degrees/training in medical/public health parasitology/entomology, cardiometabolic disease epidemiology, and biostatistics. Before joining HRI-UC, he held a Senior Research Officer in biostatistics position at the Menzies School of Health Research in Darwin, where he led/contributed to the design, implementation, and analyses of large scale randomised controlled trials (RCTs) and epidemiological studies in the Indigenous populations of Australia and sub-Sahara Africa. He has over 10 years of experience in public health, epidemiological, and applied biostatistics research across sectors - Non-governmental organisations and academia in Nigeria and Australia. In collaboration with other researchers, he has attracted over $3M in competitive National Health & Medical Research Council (NHMRC) and International-funded collaborative research grants and holds honorary research fellow appointment at the Menzies School of Health Research in Darwin and Dasman Diabetes Institute in Kuwait. He is an Editorial Board member of BMC Public Health journal.
Research Interests
* Biostatistics
* Cardiovascular disease risk factors classification
* Indigenous, migrant and international health
* Infectious diseases epidemiology (malaria, otitis media, etc)
* RCTs and epidemiological study design/analyses
* Stepped wedge cluster randomised trial design/analyses
* Health indicator and health surveys
Research Projects
* 2020 - 2025 ‘Deadly Ears at Discharge’ - A hospital-based randomised controlled trial of an additional ear and hearing assessment to inform discharge planning by a trained Aboriginal Ear Health Worker in Aboriginal children with chronic ear infection. (NHMRC Clinical Trials and Cohort Studies Grant led by Menzies School of Health Research) ~ (CI-E)
* 2018 - 2021 A randomised trial of an intensive education intervention using network of involved diabetes patients to improve glycaemic control of type 2 diabetes patients - Nigeria. Bringing Research in Diabetes to Global Environments and Systems programme (BRIDGES 2) - Funded by the International Diabetes Federation (IDF) and Eli Lilly and Company (Lilly), led by Novena University ~ (CI-B)
* 2018 - 2021 A community-based randomised trial of lifestyle intervention using targeted shared care approach on pregnancy outcomes in Nigerian women with gestational diabetes mellitus but without diabetes mellitus - Nigeria. Bringing Research in Diabetes to Global Environments and Systems programme (BRIDGES 2) - Funded by the International Diabetes Federation (IDF) and Eli Lilly and Company (Lilly) led by University of Nigeria ~ (CI-F)
Education/Academic qualification
Master, Macquarie University
… → 2019
PhD, Charles Darwin University
… → 2017
Master, Nnamdi Azikiwe University
… → 2010
Bachelor, Nnamdi Azikiwe Univerity
… → 2006
External positions
Honorary Fellow, Dasman Diabetes Institute
1 Oct 2020 → …Honorary Fellow, Menzies School of Health Research
1 Mar 2020 → …Senior Research Officer in Biostatistics, Menzies School of Health Research
30 Aug 2017 → 31 Dec 2019Academic Tutor, School of Psychological and Clinical Sciences, Charles Darwin University
1 Aug 2013 → 31 Dec 2017Fingerprint
Dive into the research topics where Victor Oguoma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
Can acute cough characteristics from sound recordings differentiate common respiratory illnesses in children? A comparative prospective study
Bisballe-Müller, N., Chang, A. B., Plumb, E. J., Oguoma, V. M., Halken, S. & McCallum, G. B., Jan 2021, In: Chest. 159, 1, p. 259-269 11 p.Research output: Contribution to journal › Article › peer-review
-
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial
Leach, A. J., Mulholland, E. K., Santosham, M., Torzillo, P. J., McIntyre, P., Smith-Vaughan, H., Wilson, N., Arrowsmith, B., Beissbarth, J., Chatfield, M. D., Oguoma, V. M., Licciardi, P., Skull, S., Andrews, R., Carapetis, J., McDonnell, J., Krause, V. & Morris, P. S., 15 Feb 2021, In: Vaccine: X. 7, p. 1-33 33 p., 100086.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1–2–4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial
Leach, A. J., Mulholland, K. E., Santosham, M., Torzillo, P. J., McIntyre, P. B., Smith-Vaughan, H. C., Wilson, N., Arrowsmith, B., Beissbarth, J., Chatfield, M. D., Oguoma, V. M. & Morris, P. S., 10 Feb 2021, In: BMC Pediatrics. 21, p. 1-14 14 p.Research output: Contribution to journal › Article › peer-review
-
10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial
Oguoma, V., Wilson, N., Mulholland, K., Santosham, M., Torzillo, P., McIntyre, P., Smith-Vaughan, H. C., Balloch, A., Chatfield, M., Lehmann, D., Binks, M. J., Chang, A. B., Carapetis, J., Krause, V., Andrews, R., Snelling, T., Licciardi, P., Morris, P. S. & Leach, A. J., 24 May 2020, In: BMJ Open. 10, 5, p. 1-11 11 p., e033511.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Acute Lower Respiratory Infections Among Indigenous Children in the Northern Territory of Australia: A Decade of Observation Spanning Three Generations of Pneumococcal Conjugate Vaccine
Binks, M., Beissbarth, J., Oguoma, V. M., Pizzutto, S. J., Leach, A. J., Smith-Vaughan, H. C., McHugh, L., Andrews, R. M., Webby, R., Morris, P. S. & Chang, A. B., 24 Mar 2020, (Submitted) In: The Lancet. p. 1-18 18 p.Research output: Contribution to journal › Article
Activities
- 1 Editorial work
-
BMC Public Health (Journal)
Victor Oguoma (Member of editorial board)
2020 → …Activity: Publication peer-review and editorial work › Editorial work